<?xml version="1.0" encoding="UTF-8"?>
<GaPExchange xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="./dbGaPEx2.1.5.xsd">

<MetaVariables>
	<Submitter/>
	<Method/>
</MetaVariables>
<MetaLinks/>

<Projects>
	<Project/>
</Projects>

<Studies>

<Study source="dbGaP" accession="phs001121.v1.p1" parentStudy="phs001121.v1.p1" createDate="2016-05-13" modDate="2016-05-13">

<Configuration>
	<Data_Provider><![CDATA[
		<table border="1">
		<tr><th>Title</th><th>Name</th><th>Institute</th></tr>
		<tr><td>Principal Investigators</td><td>William C. Hahn, MD, PhD</td><td>Dana-Farber Cancer Institute, Boston, MA, USA</td></tr>
		<tr><td>Principal Investigators</td><td>Jesse Boehm, PhD</td><td>Broad Institute, Cambridge, MA, USA</td></tr>
		<tr><td>Funding Source</td><td>U01 CA176058</td><td>Dana-Farber Cancer Institute, Boston, MA, USA</td></tr>
		</table>
	]]></Data_Provider>
	<StudyNameEntrez>Integrated Genetic and Pharmacologic Interrogation of Rare Cancers</StudyNameEntrez>
	<StudyNameReportPage>Integrated Genetic and Pharmacologic Interrogation of Rare Cancers</StudyNameReportPage>
	<StudyTypes>
		<StudyType>Cohort</StudyType>
	</StudyTypes>
	<Description><![CDATA[
<p>Due to the paucity of patient derived models in rare cancers, identification of therapeutic targets remains challenging. We developed a patient derived model, CLF-PED-015-T, from a patient with an undifferentiated sarcoma. From this model, we performed pooled RNAi and CRISPR-Cas9 negative selection screens and integrated that with a small molecule screen. Integration of these data identified CDK4 and XPO1 as potential therapeutic targets.</p>]]>
	</Description>
	<StudyInEx><![CDATA[
<p>No inclusion or exclusion criteria.</p>]]>
	</StudyInEx>
	<StudyProjects>
		<Project/>
	</StudyProjects>
	<Diseases>
		<Disease vocab_source="MESH" vocab_term="Sarcoma"/>
	</Diseases>
	<Attributions>
		<Header title="Principal Investigators">
			<AttName>William C. Hahn, MD, PhD</AttName>
			<Institution>Dana-Farber Cancer Institute, Boston, MA, USA</Institution>
		</Header>
		<Header title="Principal Investigators">
			<AttName>Jesse Boehm, PhD</AttName>
			<Institution>Broad Institute, Cambridge, MA, USA</Institution>
		</Header>
		<Header title="Funding Source">
			<AttName>U01 CA176058</AttName>
			<Institution>Dana-Farber Cancer Institute, Boston, MA, USA</Institution>
		</Header>
	</Attributions>
	<DisplayPublicSummary>yes</DisplayPublicSummary>
	<ConsentGroups>
		<ConsentGroup groupNum="1" shortName="DS-CA-MDS" longName="Disease-Specific (Cancer, MDS)"/>
	</ConsentGroups>
</Configuration>



</Study>

</Studies>

</GaPExchange>
